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Abstract—Although a wide variety of biomaterials have been
already proposed for use in bone tissue engineering, there is
still need for man-made materials, which would combine
support for osteogenesis with simplicity desirable for upscal-
ing and costs reduction. In this study we have shown that
synthetic calcite may serve as a scaffold for human
osteoblasts transplantation. A simple dynamic system allows
uniform and effective cell distribution. Cell viability and
osteogenic phenotype were conﬁrmed by XTT assay, alkaline
phosphatase activity and selected osteoblast-speciﬁc genes
expression. Extracellular matrix deposited by cells improved
elasticity and made the whole system similar to the ﬂexible
composite material rather than to the brittle ceramic
implants. It was revealed in the compression tests and also
by the improved samples handling. Subcutaneous implanta-
tion of the cell-seeded calcite scaffolds to immunodeﬁcient
mice resulted in mineralized bone formation, which was
conﬁrmed histologically and by EPR analysis. The latter we
propose as a method supplementary to histological analysis,
for bone regeneration investigations. It speciﬁcally conﬁrms
the presence of bone mineral with a unique sensitivity and
using bulk samples, which eliminates the risk of missing the
material in the preparation. Our study resulted in develop-
ment of a new osteogenic tissue engineered product based on
man-made calcite.
Keywords—Synthetic calcite, Bone tissue engineering, Hu-
man primary osteoblasts, Scaffold.
INTRODUCTION
Bone tissue engineering is one of the most inten-
sively developing areas of regenerative medicine. That
is because musculoskeletal tissues injuries are one of
the most common traumas of both young and elderly
patients due to the aging of the population combined
with a rising popularity of the active lifestyle.13,15
Currently, there are many surgical procedures based
on tissue transplantation as well as on the use of bio-
materials available for the treatment of bone defects.
Nevertheless, there are still huge expectations for new
methods of bone supply and regeneration, free from
the limitations of the currently used methods. A pos-
sibility to combine cells with the scaffolds made of
biomaterials providing the biological activity of the
implant, with no need to acquire a large amount of
tissues for transplantation represents the unique
advantage of tissue engineering. The two decades of
research on tissue engineering have resulted in various
types of biomaterials already proposed for use. How-
ever, they are still far from being faultless and the
search for new inventions is actively ongoing.21 Cur-
rent intensive research effort focuses on more ad-
vanced biomaterials intended to deliver drugs or
growth factors, capable of responding to the local
biochemical signals, like biosensors.5,12 On the other
hand, complexity and high costs of the tissue engi-
neered products (TEP) result in a gap between the
research and clinics. Therefore, it is worth reﬂection on
whether the easily available, relatively simple and as
such—more affordable materials have been sufﬁciently
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exploited in tissue engineering. Among them, synthetic
calcium carbonate might be taken into consideration
as a suitable material for scaffold preparation, mainly
for the purpose of bone tissue regeneration.
Encouraging outcomes of bone replacement using
calcium carbonates have been already reported, but
they refer only to the materials of natural origin.1,4,8
Both, results from the animal experiments and the
examples from orthopedic and maxillofacial surgery in
humans are available.3,4,8,25 Usually, the materials
based on calcium carbonates are made of corals or
mollusc shells.4,16,22 The main advantage of natural
calcium carbonates is their resorbability.4,8 However,
using natural materials has certain disadvantages,
including the limited availability of their resources—
some corals species are in danger of extinction31—and
a very limited reproducibility of the materials compo-
sition and characteristics. Synthetic calcite scaffolds, as
opposed to natural ones, could be well characterized,
prepared with established and repetitive methods and
would be widely available.
The core idea of this study is to propose syn-
thetic—and as such, free from the limitations of nat-
ural materials—calcite scaﬀolds for bone tissue
engineering. We aim to verify whether human osteo-
genic cells can be distributed within such scaﬀold,
survive and express osteogenic activity. We also pro-
pose a new calcite-based TEP with osteogenic capacity
for bone applications. The proof of concept in vivo
observation of the calcite scaffolds enriched with
human osteoblasts is performed using immunodeﬁcient
mice.
MATERIALS AND METHODS
Cells used in Experiments
For development of calcite-based TEP, human bone
derived cells (HBDCs) were used, based on the ap-
proval of the Bioethical Committee of the Medical
University of Warsaw (Approval no: KB/74/2005; KB/
116/2006).
HBDCs were isolated from the pieces of human
bone removed from the bottom distal part of the long
tight bone during knee joint alloplasty, which would
otherwise be discarded. The donors, eight female
patients, aged between 64 and 81, provided informed
consent. Cells harvested from diﬀerent donors were
cultured separately, not pooled, and the population
used in each particular experiment (ﬁrst passage) al-
ways originated from one donor. HBDCs were isolated
following the protocol for obtaining osteoblasts pro-
vided by Gallagher and colleagues.7 Brieﬂy, soft tissue
was removed from extracted bone pieces by scraping,
and bone was cut into small pieces and treated with
collagenase (Sigma, USA) overnight. Next, the bone
pieces were put into the standard culture medium
containing DMEM (Gibco, UK) enriched with 10% of
heat-inactivated FCS (Gibco, UK), 1% antibiotic–
antimycotic (Gibco, UK), 1% L-glutamine (Gibco,
UK) and 100 lM L-ascorbic acid 2-phosphate (Sigma,
USA) and left in humidiﬁed air (5% CO2, 95% relative
humidity) in order to allow osteoblasts to migrate from
bone explants onto the surface of culture bottles
(Nunc, Denmark). The medium was changed every
7 days. After conﬂuence was reached, cells were de-
tached by collagenase and trypsin (Gibco, UK) diges-
tion, and used in the experiments. Culture medium
used for experiments was enriched with HEPES
(Gibco, UK).
For the experiments performed in order to optimize
cell seeding and culture within the scaﬀolds -MG-63
(ATCC CRL-1427TM) osteoblastic cell line was used.
Cells from passage 101 were cultured in medium con-
taining DMEM enriched with 10% of FCS, 1%
antibiotic–antimycotic, 1% L-glutamine (without L-
ascorbic acid 2-phosphate) in CO2 incubator. MG-63
osteoblasts were exposed to either dynamic or static
conditions of cell culture within calcite scaffolds as
described below.
Scaﬀolds Description
Synthetic calcium carbonate scaﬀolds were manu-
factured so that the ultimate crystallographic form was
calcite. The protocol was based on the previous stud-
ies, where various forms of calcium carbonates as well
as the technical additives were tested.19 Porous calcite
scaffolds were obtained from the material containing
99 wt% of calcium carbonate CaCO3 (POCh Gliwice)
as a basic component and 1 wt% of lithium ﬂuoride
LiF (Sigma-Aldrich) as sintering activator. The mate-
rial was prepared by dry mixing of calcium carbonate
and lithium ﬂuoride powders, followed by wet milling
in rotary-vibration laboratory mill up to medium grain
size d50 = 2.8 lm. The material was dried in electric
dryer, crumbled and pulverized by sieving.
Based on our previous investigations, we have used
the method of mapping the matrix texture of poly-
urethane structural sponge in order to obtain porous
material characterized by suitable and reproducible
interconnected pore network (reticulate porous struc-
ture).9,18 Porous polymeric matrix of elastic poly-
urethane structural sponge of 45 ppi (pore per inch)
density (Bro¨sel) was used.
Samples in a shape of cylinder (15 mm in diameter
and 5 mm in height) were prepared for in vitro exper-
iments. For implantation, the cube samples were pre-
pared (5 9 5 9 5 mm). All scaffolds were sintered in
electric furnace in the temperature of 510 C. Sintering
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was performed in air. Heating rate of 50 C/h and 2 h
dwell time in the temperature of 510 C were applied
to eliminate polyurethane sponge. As conﬁrmed by
thermal analysis, performed at the set-up stage, such
ﬁring conditions secured elimination of the foam
without the need of any additional debinding treat-
ment.
Physical properties of the obtained materials were
characterized. The apparent density of the obtained
materials, measured by geometrical method, ranged
from 0.5 to 0.6 g/cm3. Total porosity of calcite mate-
rial ranged from about 75–85% and compression
strength from about 0.5 to 1.0 MPa. The size of the
pores, was measured using microstructure images from
stereoscopic and scanning microscopes and ranged
from 300 to 350 lm.10
In addition to the previously performed characteri-
zation of the material, qualitative analysis was carried
out with the use of X-ray diﬀraction method in order
to ensure the phase composition of the sintered sam-
ples prepared as a part of the TEP. Experimental setup
included Bruker-AXS D8 DAVINCI diﬀractometer
with Bragg-Brentano geometry. Measurement was
conducted at a range of 5 to 120 2h (Cu Ka) with step
size of 0.019 and measurement time of 1 s per step.
Phase identiﬁcation was carried out with the use of
PDF-4+ 2014 ICDD database.
All scaﬀolds were sterilized by irradiation with
electrons beam (10 MeV), at a dose of 25 kGy.
Cell Seeding and Culture in the Scaﬀolds: Set-Up
Observations Under Static vs. Dynamic Conditions
In order to establish protocol of eﬀective cell seed-
ing within the scaﬀolds, comparative observations of
MG-63 cell line in static vs. dynamic culture were
performed. For the ﬁrst one, scaﬀolds were placed in
the wells of a 24-well plate (Corning, USA) and seeded
with MG-63 cells at a density of 106 per scaffold. The
cells were cultured in a standard culture medium (i.e.
without L-ascorbic acid 2-phosphate) in a volume of
1.5 mL per scaffold. For a dynamic culture, commer-
cially available Spinner Basket bioreactor (New
Brunswick Scientiﬁc Company, USA) was used, as
described elsewhere.29 Brieﬂy, it is a closed system,
where a continuous movement of culture medium is
achieved by permanent mixing on a magnetic stirrer.
The ﬂow direction through the porous samples located
between the two inner strainers inside the jar is en-
forced by the speciﬁc structure of the bioreactor. The
dynamic observations were performed simultaneously
to the static ones using the same cell population. After
placing the scaffolds in a bioreactor, MG-63 osteo-
blasts suspended in 500 mL of a standard culture
medium (9 9 105 cells per sample) were added. The
whole system was located in CO2 incubator. Dynamic
and static cells culture conditions were maintained for
4 days. After this time the XTT test was performed,
then the cells were ﬁxed and stained with Hoechst
33258 (Sigma, USA) in order to localize cells nuclei.
Preparing of TEP Based on Synthetic Calcite Scaﬀold
and HBDCs in Dynamic Culture Condition
Prior to the experiment, the scaﬀolds were soaked
and incubated in standard culture medium for 24 h.
Next, samples were placed in bioreactor in a position,
which ensured a permanent ﬂow of the medium
through the scaﬀolds. HBDCs were suspended in 0.5 L
of culture medium (9 9 105 cells per sample) and put
into the bioreactor. The cells were cultured in CO2
incubator, where the whole system was placed. After
1 week the medium was changed for a fresh medium
enriched with 10 nM dexamethazone (Sigma, USA),
10 nM vitamin D3 (Sigma, USA) and 10 mM beta-
glycerophosphate (Sigma, USA). From this time point
50 mL of medium was changed twice a week. The
samples in bioreactor were cultured for 5 weeks.
In vitro Observations of HBDCs Activity and Phenotype
in TEP
Cell viability on calcite scaﬀolds (n = 6) was
examined on day 7, 14 and 35 using XTT assay (Sigma,
USA) in each from the three independent experiments.
This test is used in toxicology and is based on the
ability of mitochondrial dehydrogenase enzymes in
living cells to convert the XTT substrate [2,3-bis (2
methoxy-4-nitro-5-sulfophenyl)-5-[(phenyloamino)
carboxyl]-2H-tetrazolium hydroxide] into a water-sol-
uble formazan product. Although this test does not
measure number of cells, its results are assumed to be
proportional to the number of living cells.23 The results
of the XTT test were presented as the absorbance level.
The osteogenic capacity of the cells was conﬁrmed by
alkaline phosphatase activity test (ALP, Sigma USA)
performed after 14 and 35 days of dynamic cell cul-
ture. This colorimetric assay is based on hydrolysis of
p-nitrophenol phosphatase to p-nitrophenol.
ALP activity was normalized to cell number which
was calculated on the basis of the XTT assay per-
formed on the same cell population in parallel to the
cell growth assay.
The phenotype of the HBDCs cultured on the sur-
face of calcite scaﬀolds in the bioreactor was deter-
mined on the base of the osteogenic markers gene
expression. The total mRNA was isolated from the
HBDCs using RNeasy Micro Kit (Qiagen, Germany).
The RT-PCR method (Titan One Tube RT-PCR
Kit—Roche, Germany) was used to examine the
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expression of the genes for alkaline phosphatase
(ALP), collagen type I (Coll I) and osteocalcin (OC).
Their expression was evaluated in the material isolated
from the samples maintained in the bioreactor for 14
and 35 days. The expression of each gene was mea-
sured independently on the material isolated from at
least three scaffolds. mRNA, isolated from HBDCs
cultured on tissue culture polystyrene served as a
control. Additionally, the markers’ expression was
evaluated in the material isolated from the sub-popu-
lation of the HBDCs on the day of cell seeding (‘‘0’’
control). As a housekeeping gene GAPDH (glycer-
aldehyde-3-phosphate dehydrogenase) was used. The
gene-speciﬁc primers are shown in Table 1.
HBDCs distribution within the calcite were exam-
ined using a ﬂuorescent staining of cells nuclei
(Hoechst) followed by a microscopic observation
(NIKON ECLIPSE TE 2000-U) of the both, up and
bottom surfaces of the samples as well as at the section
in the middle of the scaﬀolds—after 7 and 35 days of a
dynamic cell culture. Additionally, TEP obtained after
35 days long culture was observed in scanning electron
microscope (HITACHI S-3500 N).
Mechanical Strength of TEP
The mechanical properties of the developed scaf-
fold-cells composites, were examined in a compression
test using LR 10 K Material Testing Machine (Lloyd
Instruments). The measuring head speed of 0.2 mm/
min and the Nexygen 3.0 software were applied. In
order to obtain a better distribution of pressure,
cardboard spacers between the compression surfaces
and the sample were applied. The test was carried out
until the load value has decreased to 80% of the
maximum load.
Cell–seeded scaﬀolds in shape of half of cylinder
(15 mm in diameter and 5 mm in height) were tested
after 5 weeks of a dynamic culture in bioreactor.
Scaﬀolds placed in a 24-well plate and incubated in a
culture medium without the addition of the cells served
as a control. Mechanical tests were performed in the
two independent experiments using the total number of
the samples equal to 12.
TEP Implantation to Animals
For in vivo observations, immunodeﬁcient SCID
mice were used because of the human-to-mouse
xenogeneicity. The animals were exposed to cyclo-
phosphamide, subcutaneously at 3 mg/animal, over
two consecutive days before the experiment. The sur-
gical procedure was conducted under general anes-
thesia. Nembutal (pentobarbital sodium) was
administered intraperitoneally (20 lg/g). Two sym-
metrical 5 mm skin dorsal cuts were performed 3 mm
away from the mouse spine, starting just under the
lower limb. Before subcutaneous scaffold implantation
two pouches were made under the dorsal muscle layer
by blunt dissection. One scaffold per pouch was in-
serted into each pocket.
Before implantation the 5/5/5 mm calcite samples
were pre-cultured with HBDCs (3 9 105 cells per
scaffold) for 2 weeks in a Spinner Basket (C+ sam-
ples) or pre-wetted in a culture medium without cells
(C2 samples)—as a control. Implantation was always
preceded by the veriﬁcation of the cell viability by
means of XTT assay. Each mouse was implanted with
one C+ and one C2 sample.
The experiment was performed twice. Each time, 22
C+ samples and 22 C2 samples were implanted. Four
and 12 weeks after implantation the animals were
euthanized and both types of the implants (C+ and
C2) with surrounding tissues were removed and pro-
ceeded for histological evaluation and EPR analysis.
The animal experiments protocol was approved by the
Animal Ethical Committee of the Medical University
of Warsaw (Approval no: 29/29.11.2005).
Histology and SEM Observation
The explants harvested after the observation period
were ﬁxed with 4% paraformaldehyde solution.
Paraﬃn sections of 7 lm were stained either with
Hematoxylin & Eosin (HE) or with Sirius Red
(SR)—for detection of the collagen orientation.
Scanning electron microscope observations of the
explanted samples were performed. The outer and the
inner surface of the TEP was observed.
Electron Paramagnetic Resonance Analysis
Electron paramagnetic resonance (EPR) spec-
troscopy visualizes the EPR-active centers in the c-ir-
radiated samples. In this study it was applied to
characterize EPR spectra with particular attention to












the bone-characteristic EPR-signals in the explants
harvested from animals. In order to generate active
centers in the investigated samples, explants were ex-
posed to the gamma irradiation using 60Co gamma
source Issledovatiel with dose rate of 1 kGy/h and a
total dose of 35 kGy. To distinguish the signals coming
from the scaffolds and from the tissues, EPR spectra
coming from the non-implanted scaffolds after radia-
tion sterilization were measured as well.
EPR analysis was performed using a Bruker ESP300
X-band spectrometer equipped with high-sensitivity
cavity ER 4108 TMH, Bruker ER035 M Gauss-
meter and microwave frequency meter HP 5342A. For
absolute g-value determination, a calibration
using diphenylpicrylhydrazyl (DPPH) at 0.1 mW
(g = 2.0036) was executed. The analysis was per-
formed at the room temperature, with modulation
frequency of 100 kHz, modulation amplitude of
0.1 mT and microwave power of 10 mW.
Statistical Analysis
The data are expressed as mean ± standard devia-
tion (SD). Statistical signiﬁcance was assessed by
analysis of variance (ANOVA) followed by Tukey post
hoc test and Mann–Whitney test. Differences at
p< 0.05 were considered to be statistically signiﬁcant.
The analysis was performed using GraphPad Prism
software.
RESULTS
Crystallographic form of Ceramic Part of the TEP -
XRD Analysis
In the XRD analysis, calcite was identiﬁed as the
main phase and LiF as a trace in the investigated cal-
cium carbonate scaﬀolds. There were no other crys-
tallographic forms identiﬁed at the level of the
sensitivity of the method, which is equal to 0.5% of the
content. The results of the analysis are shown in Fig. 1.
Observations in Cell Culture In Vitro
The inﬂuence of culture conditions on the viability
of cells growing in contact with calcite scaﬀold was
evaluated on the basis of XTT test. The test was per-
formed after 4-day culture of MG-63 cells on the sur-
face of calcite scaﬀolds. The obtained results indicate
that almost all cells cultured under static condition in
contact with the calcite samples, were dead. On the
contrary, signiﬁcantly higher (p< 0.001) cell viability
on the scaffolds in the culture performed in the
bioreactor was conﬁrmed by means of the XTT assay,
as shown in Fig. 2.
Results obtained after 5 weeks of dynamic HBDCs
culture within three dimensional calcite scaﬀolds indi-
cated that cells were not only viable but also their
number increased during the observation time
(Fig. 3a). As revealed by XTT test, the population of
FIGURE 1. X-ray diffraction analysis of calcium carbonate scaffolds. Part of the graph has been increased34.5 to better illustrate
the characteristic peaks of LiF. Identified phases: calcite CaCO3 (PDF 00-005-0586) and griceite LiF (PDF 00-004-0857)
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living cells cultured on the calcite scaffolds by day 14
was signiﬁcantly higher as compared to day 7, while on
day 35 it was signiﬁcantly higher as compared to the
living cells populations both on day 7 and 14
(p< 0.001 in all cases). Moreover, the observations in
ﬂuorescent microscope revealed the uniform cell dis-
tribution within the calcite scaffolds—on the basis of
the localization of cells nuclei visualized by a DNA-
speciﬁc Hoechst staining on the outer and inner part of
the scaffolds (Figs. 3b and 3c). Those observations
were made after 7 and 35 days of cell culture.
The ALP activity of cells cultured on the surface of
calcite scaﬀolds was determined on day 14 and 35. The
test results revealed almost 20-fold, statistically sig-
niﬁcant (p< 0.001) increase of ALP activity between
day 14 and 35 of culture (Fig. 4b).
Additionally, the HBDCs phenotype was deter-
mined on the basis of the selected genes expression.
The results of RT-PCR analysis are shown in Fig. 4a.
FIGURE 2. The results of the XTT test carried out after
4 days of static and dynamic cell culture. MG-63 cells were
cultured on the surface of 3D calcite samples. Almost all cells
cultured under static condition were dead. At the same time,
there was a high number of viable cells cultured on the calcite
scaffold under dynamic conditions in the bioreactor. The re-
sults are presented as the absorbance level: mean 6 standard
deviation (SD) (n 5 6). The differences between the groups
were statistically significant (p< 0.001) (Mann–Whitney test).
FIGURE 3. The results of the XTT test carried out on day 7, 14 and 35 of a dynamic HBDCs culture in the bioreactor (A)—the
number of cells was significantly higher in each successive time point. The results are presented as a % of day 7th result, which
was considered as 100%. Mean values 6 standard deviation (SD) are shown (n 5 6). Asterisks show significant differences
(***p< 0.001) (Mann–Whitney test). Uniform cell distribution on the 3D calcite scaffold on day 7th (B—external surface of the
scaffold) and on day 35th (C—interior of the scaffold) of dynamic culture. Cells were visualized after staining their nuclei with
Hoechst.
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Expression of the osteoblast-related genes: ALP, Coll
1, OC was conﬁrmed in the both experimental time
points, i.e. on day 14 and 35 of the HBDCs culture
within the calcite scaffolds as well as in the control.
The overall characteristics of the samples at the end
of the 5-week long observations was diﬀerent for the
scaﬀolds containing cells and those which were ex-
posed to the culture medium for the same period of
time but without cells. Tissue-like deposits were
macroscopically visible within the pores of the C+
scaﬀolds.
At the end of the mechanical tests, i.e. at the mo-
ment when the load was dropped to the value of 80%
of the maximum, the C2 samples were completely
disintegrated, while the C+ samples maintained
cohesion, and they partially recovered their original
form after removing from the machine. The load vs.
time curves registered in the mechanical compression
test revealed diﬀerent proﬁle of load resistance after
reaching the maximum value (Fig. 5). For C+ samples
the time needed to terminate the trial under the applied
rules (load drop to 80%) was equal to 16 s in average,
while for C2 samples it took about 1 s. Such sharp
decline in stress is characteristic for rigid porous
materials. The compressive strength value determined
in the compression test was equal to 1.1 MPa for the
cells-containing scaffolds and equal to 0.75 MPa for
the scaffolds without cells (Fig. 6a). This difference
was statistically signiﬁcant (p< 0.001). At the same
time SEM observations made on the same samples
revealed the presence of the extracellular matrix in the
pores of the cells-containing scaffolds (Fig. 6c).
In Vivo Observations
The general condition of the animals after surgery
and during the whole observation period was good -
there were no signs of infection or any other adverse
reactions. Animals were healthy, skin cuts were healed
and covered with fur. The calcite implants harvested
after both 4 and 12 weeks were inﬁltrated by a vas-
cularized tissue. There were no diﬀerences between
C+ and C2 samples under macroscopic observation.
The new tissue was observed deep inside the pores of
the scaﬀolds in both cases, as veriﬁed by SEM (data
not shown).
Histological observation performed on the samples
harvested 4 and 12 weeks after implantation, revealed
the presence of well-organized connective tissue inside
the calcite scaﬀolds both in C+ and C2 samples
(H&E staining, Fig. 7). The fusiform (ﬁbroblasts) cells
and occasionally also the multinucleated giant cells
were present. In focal areas of some samples slight
inﬂammatory reaction was observed. This new con-
nective tissue was rich in blood vessels in C+ and C2
samples coming from both implantation times. Also
collagen ﬁbers were present in all implants with the
exception of 4-week C2 samples. After 12 weeks of
FIGURE 4. Representative samples of agarose gel electrophoresis profiles of RT-PCR products—GAPDH, ALP, COLL 1, OC
specific genes primers were used. Analysis was performed on the selected time points in HBDCs cultured on the control surface
and in the 3D calcite scaffolds. All products exhibited appropriate sizes visualized on ethidium bromide stained gels (a). ALP
activity measured in cells cultured on 3D calcite scaffolds for 14 and 35 days. ALP activity has been shown in relation to a single
cell in culture (b). Mean values 6 standard deviation (SD) are shown (n 5 6). The differences between the groups were statistically
significant (p< 0.001) (Mann–Whitney test).
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implantation, in the scaffolds seeded with cells only,
bone tissue was found within the implants (Fig. 7).
Typical for bone trabeculae orientation of collagen ﬁ-
bers was visualized in polarized light on the sections
stained by Sirius Red (Fig. 8).
EPR analysis was used to support the histological re-
sults and to conﬁrm the presence of the mineralized bone
tissue by detecting the signals speciﬁc for bone hydrox-
yapatite. After irradiation of the explants harvested from
animal tissues, EPR spectrum contained all the signals
coming from the scaﬀold, which were revealed by the
analysis of the non-implanted irradiated scaﬀolds.
However, in the C+ samples collected 12 weeks after
implantation the additional singlet—characteristic for
bone hydroxyapatite (gx = 2.003, gy = 1.997)was found
(Fig. 9), while it was not detected either in the C2 sam-
ples or in the samples harvested after 4 weeks.
DISCUSSION
Scaﬀolds designed for tissue engineering applica-
tions should not only ﬁll in the missing tissue volume,
but also serve as a substrate for cell delivery. There-
fore, eﬀective cells distribution and their good condi-
tion within the scaﬀold are crucial. Cytocompatibility
of natural calcium carbonates was previously con-
ﬁrmed.4,6 Using synthetic calcite scaffolds for the
purpose of bone tissue engineering is a new idea, thus,
not much data on cell reaction in contact with such
material is available. First data on synthetic calcium
carbonate characteristics with regard to the cell
response were published by F. Monchau et.al only in
2013.20 The authors have shown that proliferation and
viability of mouse osteoblasts line MC3T3-E1 on the
calcite substrate signiﬁcantly diminished on day 3 and
6 as compared to the culture dish conditions but was
comparable to those observed on the calcium-phos-
phate substrates. Reduced cell proliferation but higher
ALP activity of MG-63 cell line was reported on a
FIGURE 5. The graph shows the load vs. time curves from the mechanical assay. The test was conducted after 5 weeks long
in vitro experiment on 3D calcite scaffolds without cells (a) and calcite scaffolds seeded with HBDCs (b). A characteristic feature of
3D calcite samples is charting a sharp decline in stress at the time of their destruction. The samples disintegrate completely (a).
Scaffolds seeded with cells (b) behave differently. Characteristic property of these samples is that after reaching the maximum
stress the decrease is gradual which is typical for composites and not for brittle materials.
FIGURE 6. The graph shows the compressive strength of 3D
calcite scaffolds and hybrid materials made up of calcite
scaffold and HBDCs with extracellular matrix produced by the
cells, measured after 35 days of in vitro culture. Mean val-
ues 6 standard deviation (SD) are shown (n 5 10). The dif-
ferences between the groups were statistically significant
(p< 0.001) (Mann–Whitney test) (a). SEM pictures show calcite
scaffold structure (b) and new tissue produced by HBDCs
during 35 days of dynamic culture on the 3D calcite scaffold
(c).
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calcium carbonate coating on titanium surface when
compared to uncovered titanium.14 The death of cells
observed in our experiments in the static culture, may
be related to elution of calcium ions from the residuals
which may appear as a result of the intrasintering
microdisintegration. Such residuals are difﬁcult to re-
move even by prolonged washing—due to the high
roughness and complexity of the material structure.
Moreover, during sintering of a material consisting of
calcium carbonate and lithium ﬂuoride a slight
decomposition of CaCO3 may occur under the inﬂu-
ence of the temperature, as well as the formation of
small amounts of amorphous Ca-rich phase. Both
phenomena result in an increased release of calcium
ions, which locally alkalizes the culture medium and
reduces cell viability. The potential role of LiF is
important for the further improvement of CaCO3-
based TEPs and demands for further studies. Never-
theless, the problem of cytotoxicity induced with local
alkalization of the medium was successfully resolved in
our dynamic Spinner Basket system, which provided
constant movement of the medium with a volume of
0.5 L. We obtained more than doubling and tripling of
the population on day 14 and 35 in the culture on the
calcite scaffold by applying this relatively simple sys-
tem of dynamic culture (Figs. 2 and 3). Signiﬁcant
beneﬁt of applying dynamic systems over the standard
static culture condition is a known fact and was
observed in many experiments before.17,27,30 It results
also in the improved cells distribution in the 3D
structures. In our experiments cells were observed not
only on the upper and the bottom side of the scaffolds,
but also on the entire surface of the cross-section of the
samples (Figs. 3b and 3c). This is a result of effective
cells nourishment due to the medium ﬂow. It also
conﬁrms the suitable scaffold architecture with its open
porosity and pore size of about 300–500 lm—known
to be appropriate for tissue ingrowth and bone
regeneration after implantation in vivo.2 The results of
the in vivo observations of the HBDCs -containing
calcite-based system developed in our study seems
encouraging. They revealed the formation of the min-
eralized bone tissue inside the pores of the scaffolds
12 weeks after subcutaneous implantation to immun-
odeﬁcient SCID mice (Fig. 7). Since this effect was
found only in the implants containing HBDCs seeded
FIGURE 7. Histological pictures of the explants harvested 12 weeks after implantation (HE staining)—higher magnification at the
bottom line. On the left side—pictures from the group where the naked, i.e. not-seeded with cells, scaffolds were implanted (C2).
On the right side—pictures from the group where the implanted scaffolds were seeded with cells prior to implantation (C+). Only in
calcites seeded with HBDCs before implantation bone tissue was found within the implants.
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in the scaffolds, but not in the naked, i.e. non-seeded
with cells scaffolds, it must have involved the osteo-
genic activity of the implanted cells. Their osteogenic
capacity was conﬁrmed in vitro prior to implantation.
During 5-weeks long culture we observed signiﬁcant
increase of ALP activity in response to differentiation
culture medium—which is widely accepted marker of
the cells osteogenic potency.7,11 Moreover, the osteo-
blast-related genes expression, namely: ALP, Collagen
type I and Osteocalcin—a speciﬁc marker of osteo-
blasts, was conﬁrmed in HBDCs cultured within cal-
cite scaffolds by means of RT-PCR (Fig. 4a). All those
data conﬁrm that HBDCs cultured on the synthetic
calcite scaffolds under dynamic conditions save their
osteogenic function.
Moreover, the developed scaﬀolds must have
delivered the desirable ions to the implantation site,
which allows to organize not only extracellular bone
matrix of the appropriate protein content, but fully
mineralized tissue. In our previous investigations, we
conﬁrmed osteogenic capacity of HBDCs implanted
on the polyurethanes scaﬀolds in the analogous in vivo
system, but we did not obtain mineralized bone tissue
there.29 In the current study, when calcite scaffold is
applied, the presence of the mineralized bone was
proved both by histological evaluation (Figs. 7 and 8)
and by the EPR study (Fig. 9). The latter we propose
as a supplementary method, in parallel to the histo-
logical analysis, for the bone regeneration investi-
gations—as the extremely credible bone mineral
detection technique. EPR spectroscopy allows deter-
mination of the structure of radicals and EPR-active
centers created in the irradiated samples. Its usefulness
for bone tissue characterization comes from the fact,
that in the biominerals containing hydroxyapatite,
such as tooth enamel or bone, irradiated with ionizing
radiation, characteristic paramagnetic centers are
induced.24 They can be detected by EPR with a very
high sensitivity, are extremely stable in time and their
intensity responds in a controlled manner to the dosage
of irradiation, which makes it useful for bone dating,
dosimetry in tissues containing bone hydroxyapatites
and detecting the remodeling of irradiated bone grafts
in experimental systems.26,28
For characterization of bone TEPs, the two very
important advantages of using EPRmay be underlined.
Firstly, it can be applied to the full volume sample, while
being extremely sensitive at the same time. This helps to
avoid artifacts that may arise from the omission of
FIGURE 8. Histological pictures of a bone trabeculae, present in the explants harvested 12 weeks after implantation of the
scaffolds which were seeded with cells prior to implantation. This bone trabeculae corresponded to the area of collagen deposition
as has been confirmed by Sirius Red staining. Pictures A and B represent the same explant’s place stained with Sirius Red and
visualized in transmitted light (a) and polarized light (b), respectively.
FIGURE 9. EPR spectra of calcite scaffolds. Arrows indicate
perpendicular and parallel components of signal in bone
(g(per) 5 2.003, g(para) 5 1.997).
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interesting pieces of tissues during sectioning, which can
easily happen when the presence of the scaﬀold does not
allow for serial sectioning. Although there is a broad
range of methods to detect selected ions present in the
sample, the EPR is superior to other techniques as it
reveals the signal characteristics not for a group of ions,
but just the bone hydroxyapatite. In our study EPR
analysis conﬁrmed the presence of the paramagnetic
signal characteristic for bone mineral in the explants
consisting of calcite scaﬀolds and HBDCs harvested
12 weeks after implantation. Therewas not such a signal
neither in the samples which did not contain the human
cells nor in the explants harvested earlier, i.e., 4 weeks
after surgery, regardless of whether they contained
HBDCs or not. These results are in an accordance with
the histological evaluation and prove osteogenic po-
tency of the calcite scaﬀolds enriched with human os-
teoblasts.
Subcutaneous osteogenesis of the cells-containing
tissue engineering systems is not unique for the calcite-
based systems. Similar results have been already pub-
lished for calcium phosphate scaﬀolds,32 which are the
most often studied biomaterials for bone reconstruc-
tion. Some studies show a promising results of the
research performed on the calcium carbonates con-
verted to hydroxyapatite by hydrothermal exchange.31
Our results prove the osteogenic potential of the pro-
duct based on a simple synthetic calcite without any
additional chemical treatment. Simplicity of the system
may be crucial when transition from the bench to the
clinical scale of the medical devices or medicinal
products application is considered, and the manufac-
turing costs may limit the application. The techno-
logical regime for a single-phase material, such as
calcite, may be less demanding as compared to the
multiphase products, which seem to be the most
required variant of calcium phosphates. While the
technology of obtaining well-controlled ceramic-based
scaffolds has long been mastered, a simplicity of the
material may be a beneﬁt, especially when up-scaling
and reproducibility of the ﬁnal product is considered.
Another issue important for the characteristics of
the developed calcite-based system is its mechanical
properties. The compressive strength of the naked, i.e.
not seeded with cells scaﬀolds is low (Fig. 6)—as a
consequence of high porosity of the samples. However,
our results show that the prolonged—up to 35 days
long culture of the cells distributed within the scaffold
is possible. Both cell viability and osteogenic pheno-
type at this time point was conﬁrmed (Figs. 3 and 4).
Such prolonged culture results in obtaining a structure
of a composite containing calcite and tissue-like
structure—as visualized in SEM (Fig. 6). The mechan-
ical tests conﬁrmed a composite-like nature of the cells-
enriched scaffolds. The compressive strength of such
structure is slightly, but statistically signiﬁcantly higher
(p< 0.001) as compared to the naked scaffold. But
what is even more important, characteristics of the
destruction is different. In the case of brittle scaffolds,
it is typical to observe a sharp decline in stress at the
time of their destruction, as was demonstrated for
scaffolds without cells. On the contrary, behavior of
cell-enriched scaffolds in mechanical tests is charac-
teristic for the polymer-ceramic composites, in which a
porous brittle material is partially ﬁlled with the elastic
one. Therefore, we postulate that the calcite-based
scaffolds enriched with cells and supported by the cell-
deposited ECM offer the improved handling of the
ceramic-based bone grafts. They are much less brittle
than ceramics alone and may be even slightly modiﬁed
in shape in the operating theater, which is expected by
surgeons. The osteogenic potency of such a system
calls for further preclinical study. However, the os-
teogenic phenotype conﬁrmed in vitro in the prolonged
culture as well as the approved in vivo osteogenic po-
tency of the analogous system after shorter culture
seems highly encouraging.
CONCLUSIONS
Synthetic calcite may be proposed as a material for
scaﬀolds used in bone tissue engineering. We show that
it maintains proliferative potency as well as osteogenic
capacity of human osteoblasts distributed and grown
within the scaﬀold in a dynamic culture. Osteogenic
properties of the developed calcite-based TEP were
conﬁrmed in vivo in the subcutaneous model in
immunodeﬁcient mice as well. The applied scaffolds,
which were shown to be overgrowth by a mineralized
bone tissue after implantation to soft tissues, were not
converted to hydroxyapatite by hydrothermal ex-
change, but were used after standard sintering. We
underline the simplicity of this monophasic, easy to
obtain substrate for cell transplantation, which main-
tain control and repeatable characteristics unlike the
calcium carbonates of natural origin. We also devel-
oped the osteogenic bone substitute, supported by the
extracellular matrix deposited by the cells in the pro-
longed culture. It has a composite-like mechanical
characteristics instead of a brittle one as well as the
improved surgical handling.
We postulate applying EPR analysis, which may
conﬁrm the presence of mineralized bone with a unique
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sensitivity and free from the risk of missing the mate-
rial due to the preparation, as a method supplementary
to the histological analysis, for bone regeneration
investigations.
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